Correlation Between Mereo BioPharma and Annexon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Annexon, you can compare the effects of market volatilities on Mereo BioPharma and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Annexon.

Diversification Opportunities for Mereo BioPharma and Annexon

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Mereo and Annexon is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Annexon go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Annexon

Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 1.26 times more return on investment than Annexon. However, Mereo BioPharma is 1.26 times more volatile than Annexon. It trades about -0.18 of its potential returns per unit of risk. Annexon is currently generating about -0.42 per unit of risk. If you would invest  428.00  in Mereo BioPharma Group on September 2, 2024 and sell it today you would lose (67.00) from holding Mereo BioPharma Group or give up 15.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Mereo BioPharma Group  vs.  Annexon

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Annexon 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Annexon are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Annexon is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Mereo BioPharma and Annexon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and Annexon

The main advantage of trading using opposite Mereo BioPharma and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.
The idea behind Mereo BioPharma Group and Annexon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance